IV occlusion and vitamin E

July 26, 2008

Email this news item to a friend/colleague

Chernecky et al (2008) published a study in which patients felt that taking vitamin E, 400 -800 IU per day orally, avoided the problems of occlusion or inability to withdraw blood from their current VAD.

Chernecky, C., Macklin, D., Nugent, K. and Waller, J. (2008) Potential Value of Vitamin E in Cancer Patients with Venous Access Devices. Journal of the Association for Vascular Access. 13(2), p. 71-73.

Abstract:

Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs.

Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer.

Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD).

Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD.

Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.